# CaraMed Capital

CaraMed Capital is an Institutional Investor based in Auckland, New Zealand.

## Overview

- **Organization type:** Institutional Investor
- **Headquarters:** Auckland, New Zealand
- **Address:** Auckland, New Zealand
- **Assets under management:** $50 million
- **Website:** caramed.co.nz
- **LinkedIn:** https://www.linkedin.com/sales/company/69682924

## Regulatory record

- **Reports private funds:** No

## About

CaraMed Capital is a New Zealand-based healthcare venture capital fund founded in 2020 and headquartered in Auckland. The firm operates as an institutional investor with $50 million in assets under management. CaraMed Capital focuses on investing in healthtech companies located in New Zealand. The firm's portfolio includes one known investment in Xylo Bio, made as part of their Seed VC - II fund on October 27, 2022. As a specialized healthcare VC, CaraMed Capital targets seed-stage opportunities within the health technology sector, supporting the growth of innovative healthtech ventures in the New Zealand market.

## Sectors

- Institutional Investor
- New Zealand

## Questions

### What is CaraMed Capital's investment focus?

CaraMed Capital focuses on investing in healthtech companies based in New Zealand, targeting seed-stage opportunities within the healthcare technology sector.

### How much does CaraMed Capital have in assets under management?

CaraMed Capital has $50 million in assets under management.

### Where is CaraMed Capital headquartered?

CaraMed Capital is headquartered in Auckland, New Zealand.

---

Last updated: 2026-07-13T07:53:37.000Z

Canonical page: https://altss.com/profile/caramed-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology